Concepedia

Rhamy Zeid

RZ

Statistics

Publications

15

Citations

3.9K

H-Index

14

Active since

2011

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Broad Institute

Boston Children's Hospital

Brigham and Women's Hospital

Rhamy Zeid is an author at Dana-Farber Cancer Institute specializing in molecular oncology, oncology, and medicine.

Publications per year

2011–2022

15

Publications

15

Melanoma genome sequencing reveals frequent PREX2 mutations

Michael F. Berger, Eran Hodis, Timothy P. Heffernan et al. · Nature · 2012 · 766 citations · Full text

Life Sciences, Genetics, Oncology +17

Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

Alexandre Puissant, Stacey M. Frumm, Gabriela Alexe et al. · Cancer Discovery · 2013 · 633 citations · Full text

Medicine, Cancer Biology, Oncology +16

BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment

Georg E. Winter, Andreas Mayer, Dennis L. Buckley et al. · Molecular Cell · 2017 · 490 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Active medulloblastoma enhancers reveal subgroup-specific cellular origins

Charles Y. Lin, Serap Erkek, Yiai Tong et al. · Nature · 2016 · 399 citations · Full text

Medicine, Genetics, Molecular Genetics +14

BET Bromodomain Inhibition of <i>MYC</i> -Amplified Medulloblastoma

Pratiti Bandopadhayay, Guillaume Bergthold, Brian T. Nguyen et al. · Clinical Cancer Research · 2013 · 351 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 15